scholarly journals Omega-3 Fatty Acids in Adipose Tissue and Risk of Myocardial Infarction

1999 ◽  
Vol 19 (4) ◽  
pp. 1111-1118 ◽  
Author(s):  
Eliseo Guallar ◽  
Antti Aro ◽  
F. Javier Jiménez ◽  
José M. Martín-Moreno ◽  
Irma Salminen ◽  
...  
Author(s):  
Thomas Andersen Rix ◽  
Pia Dinesen ◽  
Søren Lundbye‐Christensen ◽  
Albert Marni Joensen ◽  
Sam Riahi ◽  
...  

2018 ◽  
Vol 50 (1) ◽  
pp. 71-82 ◽  
Author(s):  
Martin Gajdošík ◽  
Lukas Hingerl ◽  
Antonín Škoch ◽  
Angelika Freudenthaler ◽  
Patrik Krumpolec ◽  
...  

2018 ◽  
Vol 64 ◽  
pp. 147-160 ◽  
Author(s):  
Ondrej Kuda ◽  
Martin Rossmeisl ◽  
Jan Kopecky

2014 ◽  
Vol 9 (10) ◽  
pp. 1676-1683 ◽  
Author(s):  
Ellen K. Hoogeveen ◽  
Johanna M. Geleijnse ◽  
Daan Kromhout ◽  
Theo Stijnen ◽  
Eugenie F. Gemen ◽  
...  

2016 ◽  
Vol 67 (13) ◽  
pp. 39
Author(s):  
Seung-Woon Rha ◽  
Min Shim ◽  
Byoung Geol Choi ◽  
Se Yeon Choi ◽  
Jae Kyeong Byun ◽  
...  

Author(s):  
Jean-Yves LE GUENNEC ◽  
Forel Céline ◽  
Messager Laureen ◽  
Sierra Camille ◽  
Contreras Ivette ◽  
...  

Up to the middle of the 2000’s, omega 3 polyunsaturated fatty acids were considered has having cardioprotective properties. Patients having a myocardial infarction were supplemented with these fatty acids in secondary prevention of myocardial infarction. Since then, many randomized clinical trials failed to observe the cardioprotective effects previously described. The main hypothesis to explain such change is the systematic prescription of statins to patients following a myocardial infarction, statins interfering with the homeostasis of omega 3 fatty acids. This review discusses the effects of different forms of omega-3 in association with statins on cardiovascular disease and emphasize on the interaction between statins and omega 3 fatty acids leading to the possible need to use higher dose of fatty acids to get a synergistic effect.


Sign in / Sign up

Export Citation Format

Share Document